SCHEMBL6710077

SCHEMBL6710077

O=C(Cc1ccc(F)cc1)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.38
POLB P06746 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
GRIK1 P39086 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GPR35 Q9HC97 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
PLA2G7 Q13093 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707815 0.93 PARP14 (0.42) POLBRXFP1TP53MAPTGRIK1
SCHEMBL6710051 0.93 MEN1 (0.40) CASP3GRIK1MEN1KMT2AGPR35
SCHEMBL6711736 0.92 GPR35 (0.38) RXFP1MAPTGRIK1GPR35HDAC1
SCHEMBL6711425 0.92 PARP14 (0.40) MAPTGRIK1MEN1KMT2AGPR35
SCHEMBL6707655 0.92 GRIK1 (0.45) POLBMAPTGRIK1MEN1KMT2A
SCHEMBL6708656 0.92 GRIK1 (0.37) GRIK1MEN1KMT2A
SCHEMBL6709043 0.91 GRIK1 (0.37) GRIK1MEN1KMT2A
SCHEMBL6713651 0.91 MEN1 (0.44) GRIK1MEN1KMT2AHDAC3HDAC1
SCHEMBL6710325 0.91 RXFP1 (0.40) CASP3POLBRXFP1TP53MAPT
SCHEMBL6711738 0.90 GRIK1 (0.38) CASP3TP53MAPTGRIK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 CASP3 250/4885POLB 626/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.